Literature DB >> 26857755

The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws.

Thomas Mücke1, Steffen Koerdt2, Maximilian Jung2, David A Mitchell2, Klaus-Dietrich Wolff2, Marco Rainer Kesting2, Denys John Loeffelbein2.   

Abstract

INTRODUCTION: Surgical treatment of bisphosphonate-related osteonecrosis of the jaws (BRONJ) combines excision of adequate damaged bone and watertight coverage by appropriate vascularized tissue. Local tissues are preferred when possible. This study compares local mucoperiosteal flaps with mylohyoid flaps with special emphasis on their influence on wound healing.
MATERIAL AND METHODS: A total of 195 patients with BRONJ in the mandible were included in this prospective study. The control group (n = 169) were treated with a mucoperiosteal flap, whereas patients of the study group (n = 26) received a mylohyoid flap.
RESULTS: Recurrence of BRONJ was significantly reduced (p = 0.023) as was extent of necrosis (p = 0.001) in patients with mylohyoid flaps. DISCUSSION: This study demonstrates the importance of a sufficient mucosal coverage in surgical treatment of BRONJ. The mylohyoid flap provides an additional tissue coverage, which seems to account for the significantly reduced rate of disease recurrence.
CONCLUSION: The vascularized mylohyoid flap is an important tool in the complex and challenging surgical care of BRONJ.
Copyright © 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bisphosphonates; Jaws; Microvascular free flap; Osteonecrosis; Recurrence; Treatment outcome

Mesh:

Substances:

Year:  2016        PMID: 26857755     DOI: 10.1016/j.jcms.2015.12.017

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  7 in total

1.  Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam.

Authors:  Anton Straub; Andreas Vollmer; Thiên-Trí Lâm; Roman C Brands; Maximilian Stapf; Oliver Scherf-Clavel; Max Bittrich; Andreas Fuchs; Alexander C Kübler; Stefan Hartmann
Journal:  Clin Oral Investig       Date:  2022-08-09       Impact factor: 3.606

2.  Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.

Authors:  Mitsunobu Otsuru; Saki Hayashida; Kota Morishita; Maho Murata; Sakiko Soutome; Miho Sasaki; Yukinori Takagi; Misa Sumi; Masahiro Umeda
Journal:  Int J Environ Res Public Health       Date:  2022-06-17       Impact factor: 4.614

3.  Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients.

Authors:  Kota Morishita; Sakiko Soutome; Mitsunobu Otsuru; Saki Hayashida; Maho Murata; Miho Sasaki; Yukinori Takagi; Misa Sumi; Masahiro Umeda
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

4.  Application of a collagen scaffold saturated with platelet-rich plasma in prevention of bisphosphonate-related osteonecrosis of the jaw in the rat animal model.

Authors:  Farnoosh Razmara; Mohammad Bayat; Sadegh Shirian; Ghazal Shabankare; Abdolreza Mohamadnia; Mostafa Mortazavi; Mohammad-Reza Alijani; Naghmeh Bahrami
Journal:  Heliyon       Date:  2021-05-01

5.  Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).

Authors:  Thomas Ziebart; Frank Halling; Paul Heymann; Andreas Neff; Sebastian Blatt; Junho Jung; Andreas Pabst; Leonardo Righesso; Christian Walter
Journal:  Dent J (Basel)       Date:  2016-10-25

Review 6.  Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches.

Authors:  Sung-Woon On; Seoung-Won Cho; Soo-Hwan Byun; Byoung-Eun Yang
Journal:  Antioxidants (Basel)       Date:  2021-04-27

7.  The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction.

Authors:  Sang-Hoon Kang; Se-Jin Park; Moon-Key Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.